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A B S T R A C T
We report a case of synchronous bilateral breast cancer with ductal and medullary carcinoma. A 60-year-old woman
presented with lesion in both breasts which were mammographicaly found two years ago. Ultrasonography proved two
suspected masses in breasts. Fine needle cytology was performed and confirmed bilateral carcinoma but with different
cytological findings. The cytological feature of the left breast suggested ductal carcinoma and of the right breast raised
possibility of a medullary carcinoma. Patient underwent bilateral quadrectomy with evacuation of axillary lymph nodes.
Histological examination showed bilateral carcinoma with two different histological features: ductal in the left and
medullary carcinoma in the right breast.
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Introduction
Bilateral synchronous breast cancer is an uncommon
event and accounts for 0.3–12% of all breast cancers1. Bi-
lateral breast cancer was defined as synchronous when
contralateral cancer was identified within 6 months2
(some physicians consider 3 months and others one
year)1,3 after the first breast cancer. Synchronous bilat-
eral tumours are considered independent when they
have characteristics like presence of an intraductal com-
ponent, different histologies or different degrees of dif-
ferentiation4. Different histological types form 20–30% of
bilateral synchronous breast cancer5. This is a case with
concurrent invasive ductal and medullary carcinoma.
Case Report
A 60-year-old woman without family history of breast
cancer was referred to our hospital for regular breast ex-
amination. The patient came with two years old mam-
mographic finding made in another hospital. It showed
two masses in breasts: one in the left breast, in the upper
outer quadrant and one in the right breast, on the border
of outer quadrants. Two years ago it was considered that
neither of these masses required additional diagnostic
procedures.
She had a firm mobile palpable lesion about 8 mm in
its largest diameter, in the upper outer quadrant of her
left breast. Ultrasound examination confirmed there sus-
pected mass, 10 mm in diameter. No masses were pal-
pated in left axilla. In her right breast there was a firm
mobile palpable mass, about 20 mm in diameter, on the
border of outer quadrants. Ultrasound examination con-
firmed it as an irregular hipoehogenic mass 10 mm in di-
ameter. She hadn’t palpable masses in right axilla.
Fine needle aspiration cytology was performed using
22-gauge needle. Slides were air-dried and stained using
the May-Grünwald-Giemsa method. Cytological exami-
nation confirmed bilateral cancer. Cytology finding of the
lesion in the left breast was ductal carcinoma with epi-
thelial cells round and oval in shape with atypical fea-
tures, variation in size and nuclear moulding (Figure 1
and 2). Aspirates of fine needle aspiration cytology of
right breast, predominantly consisted of structureless
sheets of large pleomorphic cells, sometimes with bi-
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zarre-shaped nuclei and prominent nucleoli admixed
with lymphocytes and plasma cells (Figure 3 and 4).
Medullary carcinoma was suggested but diagnosed
only as carcinoma because small areas of lymphoid stro-
ma are quite common in high grade ductal carcinoma, so
only histology can confirmed medullary carcinoma using
criteria proposed by Ridolfi6.
Based on cytology findings, the patient underwent
surgical treatment: bilateral quadrectomy with evacua-
tion of axillary lymph nodes. Intraoperative cytology con-
firmed bilateral carcinoma but of two different types: left
as ductal and right suggested possibility of medullary
carcinoma. Histopathological examination of the left breast
confirmed invasive ductal carcinoma, 5 mm in diameter,
with 90% estrogen receptor positive cells and 60% pro-
gesteron receptor positive cells by immunohistochemical
staining. HER2 was negative. Tumor was composed of
atypical epithelial moderately differentiated cells arran-
ged in tubules and sheets in dense collagenous stroma.
Seven axillary lymph nodes were free of tumor.
The lesion from the right breast was histologically di-
agnosed as a medullary carcinoma, 15 mm in diameter,
with numerous large atypical malignant cells arranged
in solid sheets. A dense lymphoplasmacytic infiltrate was
observed in the background. There were no estrogen and
progesteron receptor positive cells in tumor. HER2 was
negative. Thirteen axillary lymph nodes were free of tu-
mor.
According to Elston-Ellis histological grading of bre-
ast cancer, ductal carcinoma was evaluated as grade 2
with 6 degree (2 for tubule formation, 2 for nuclear
pleomorphism and 2 for mitoses) and medullary carci-
noma as grade 3 with 9 degree (3 for tubule formation, 3
for nuclear pleomorphism and 3 for mitoses). The patient
received postoperative adjuvant chemotherapy. When seen
in follow-up (in November 2008) 41 months postdiagno-
sis, the physical and mammographical exam findings
were negative for metastatic or recurrent disease.
Discussion and Conclusion
Patient with breast cancer have an increased risk of
developing either a synchronous or metasynchronous
breast cancer which ranges between 0.5% and 0.8% each
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Fig. 1. Ductal carcinoma cells grouped in loose aggregate show
atytipical features with nuclear moulding and variation in size
(May-Grünwald-Giemsa stain, x200).
Fig. 2. The nuclei of ductal carcinoma cells vary considerably in
size and have round or oval shape with little nuclear border ir-
regularity (May-Grünwald-Giemsa stain, x600)
Fig. 3. Structurless sheet of large pleomorphic medullary carci-
noma cells with lymphoplasmacytic infiltrate in the background
(May-Grünwald-Giemsa stain, x100).
Fig. 4. A large atypical medullary carcinoma cell with prominent
nucleoli admixed with lymphocytes and plasma cells (May-
-Grünwald-Giemsa stain, x400).
year7. Several reports showed that the prognosis in bilat-
eral breast carcinoma was worse than that of unilateral
breast carcinoma8–11 and traditional approach to bilat-
eral breast carcinoma is more aggressive than approach
to unilateral disease1. However, several studies have shown
that the prognosis of patients with synchronous bilateral
breast carcinoma seems similar to unilateral disease11–13.
Increase in the incidence of synchronous disease during
1970s coincides with the introduction of routine bilateral
mammography in the diagnostic work-up in women with
unilateral cancer14. This support the role of careful scre-
ening of the contralateral breast and follow-up of all pa-
tients diagnosed with breast cancer1.
The most common breast cancer histologic subtype is
infiltrating ductal carcinoma; however, lobular carcino-
ma is tumour type associated with diffuse or multifocal
growth pattern and bilaterality15. Medullary carcinoma
of the breast is a special type of tumor accounting for
1–6% of all breast carcinomas. It has a better prognosis
than the infiltrating ductal carcinoma and than the high
degree of epithelial atypia would predict16 if strict histo-
logical criteria proposed by Ridolfi are used. Clinically
and mammographically it is a well demarcated lesion and
can be mistaken for a fibroadenoma, a colloid or a papil-
lary carcinoma. Cytologists are still facing some difficul-
ties in determining some breast tumour subtypes17 and
medullary carcinoma is one of them. The cytological fea-
tures of medullary breast carcinoma are rarely detailed
in the literature. Based on its cytological features, differ-
ential diagnoses are: a poorly-differentiated ductal carci-
noma with a lymphocytic infiltrate, metastatic carci-
noma in an intramammary lymph node and malignant
lymphoma. Nevertheless, it is possible on breast fine nee-
dle cytology to suggest that this may be a medullary car-
cinoma but it must be histologically confirm using the
criteria proposed by Ridolfi6.
Family history and early age of onset have been re-
ported to increase risk of contralateral breast carcinoma
development18 but other studies have found no such
associations19. Some reports showed that synchronous
cancers are biologically closer to some clonal lesions
(metastatic lesions) than metachronous cancers. A bio-
marker, such as progesteron receptor status, plays a role
in addition to the histological parameters, in differentiat-
ing metastatic cancers from secondary primary cancers.
The rates of the same histopatological type were 93% in
synchronous cancers and only 59% in metachronous
cancers2.
The incidence of synchronous cancer is similar to inci-
dence of unilateral disease but in metachronous cancers
is much more common in younger patients from 1980s
probably because of the expanding use of adjuvant sys-
tematic therapy3. Some studies have shown similar prog-
nosis for patients with unilateral and bilateral breast
cancer. Gollamudi et al. showed that patients with syn-
chronous bilateral breast cancer don’t have a worse prog-
nosis and can be safely treated with bilateral breast con-
serving surgery1.
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ISTOVREMENI OBOSTRANI KARCINOM DOJKE RAZLI^ITOG MORFOLO[KOG SUBTIPA: PRIKAZ
SLU^AJA
S A @ E T A K
Prikazujemo slu~aj istovremenog obostranog karcinoma dojke: duktalnog i medularnog. Radi se o 60-ogodi{njoj `eni
s obostranim promjenama u dojkama koje su mamografski utvr|ene dvije godine ranije. Ultrazvu~ni pregled potvr|uje
nalaz dviju suspektnih promjena u dojkama. Citolo{kom punkcijom dijagnosticira se obostrano karcinom ali s raz-
li~itom citolo{kom slikom. Citolo{ki nalaz lijeve dojke upu}ivao je na duktalni karcinom, a desne dojke postavio sumnju
na medularni karcinom. Pacijentici se u~ini obostrana kvadrektomija sa evakuacijom aksila. Histolo{ki pregled potvr-
|uje karcinom dojke obostrano i to razli~itog histolo{kog subtipa: duktalni karcinom u lijevoj, a medularni u desnoj
dojci.
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